Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors.
Varuni Kondagunta G, Bacik J, Schwartz L, Sheinfeld J, Bajorin D, Vuky J, Marion S, Mazumdar M, Bosl GJ, Motzer RJ.
Varuni Kondagunta G, et al. Among authors: bajorin d.
Invest New Drugs. 2004 Apr;22(2):177-9. doi: 10.1023/B:DRUG.0000011794.21608.59.
Invest New Drugs. 2004.
PMID: 14739666
Clinical Trial.